Download
https://www.ndtvprofit.com/markets/sun-pharma-to-get-rs-169-crore-in-patent-settlement-with-biofrontera?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Dusa Pharmaceuticals Inc. agreed to settle a patent infringement lawsuit it had filed against the Biofrontera group.
Share